Department of Biotherapy, Medical Center for Digestive Diseases, Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210011, China.
Affilated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, China.
Mol Med. 2021 Jun 6;27(1):57. doi: 10.1186/s10020-021-00325-z.
Acetaminophen (APAP) overdose causes hepatotoxicity and even acute liver failure. Recent studies indicate that sterile inflammation and innate immune cells may play important roles in damage-induced hepatocytes regeneration and liver repair. The scavenger receptor CD36 has its crucial functions in sterile inflammation. However, the roles of CD36 in APAP induced acute liver injury remain unclear and warrant further investigation.
WT C57BL/6 J and CD36 mice were intraperitoneally injected with APAP (300 mg/kg) after fasting for 16 h. Liver injury was evaluated by serum alanine aminotransferase (ALT) level and liver tissue hematoxylin and eosin (H&E) staining. Liver inflammatory factor expression was determined by real-time polymerase chain reaction (PCR). The protein adducts forming from the metabolite of APAP and the metabolism enzyme cytochrome P450 2E1 (CYP2E1) levels were measured by Western blot. Liver infiltrating macrophages and neutrophils were characterized by flow cytometry. RNA sequencing and Western blot were used to evaluate the effect of damage-associated molecular patterns (DAMP) molecule high mobility group B1 (HMGB1) on WT and CD36 macrophages. Moreover, PP2, a Src kinase inhibitor, blocking CD36 signaling, was applied in APAP model.
The expression of CD36 was increased in the liver of mice after APAP treatment. Compared with WT mice, APAP treated CD36 mice show less liver injury. There was no significant difference in APAP protein adducts and CYP2E1 expression between these two strains. However, reduced pro-inflammatory factor mRNA expression and serum IL-1β level were observed in APAP treated CD36 mice as well as infiltrating macrophages and neutrophils. Moreover, CD36 deficiency impaired the activation of c-Jun N-terminal kinase (JNK) caused by APAP. Interestingly, the lack of CD36 reduced the activation of extracellular regulated protein kinases (Erk) and v-akt murine thymoma viral oncogene homolog (Akt) induced by HMGB1. RNA transcription sequencing data indicated that HMGB1 has a different effect on WT and CD36 macrophages. Furthermore, treatment with PP2 attenuated APAP induced mouse liver injury.
Our data demonstrated that CD36 deficiency ameliorated APAP-induced acute liver injury and inflammatory responses by decreasing JNK activation. CD36 might serve as a new target to reduce acute liver injury.
对乙酰氨基酚(APAP)过量会导致肝毒性甚至急性肝衰竭。最近的研究表明,无菌炎症和先天免疫细胞可能在损伤诱导的肝细胞再生和肝脏修复中发挥重要作用。清道夫受体 CD36 在无菌炎症中具有关键功能。然而,CD36 在 APAP 诱导的急性肝损伤中的作用仍不清楚,需要进一步研究。
禁食 16 小时后,WT C57BL/6J 和 CD36 小鼠经腹腔注射 APAP(300mg/kg)。通过血清丙氨酸氨基转移酶(ALT)水平和肝组织苏木精和伊红(H&E)染色评估肝损伤。通过实时聚合酶链反应(PCR)测定肝炎性因子表达。通过 Western blot 测定 APAP 代谢物和代谢酶细胞色素 P450 2E1(CYP2E1)形成的蛋白加合物水平。通过流式细胞术鉴定肝浸润巨噬细胞和中性粒细胞。用 RNA 测序和 Western blot 评估损伤相关分子模式(DAMP)分子高迁移率族蛋白 B1(HMGB1)对 WT 和 CD36 巨噬细胞的影响。此外,应用Src 激酶抑制剂 PP2 阻断 CD36 信号,用于 APAP 模型。
APAP 处理后,小鼠肝组织中 CD36 表达增加。与 WT 小鼠相比,APAP 处理的 CD36 小鼠肝损伤较小。两种菌株之间 APAP 蛋白加合物和 CYP2E1 表达无显著差异。然而,在 APAP 处理的 CD36 小鼠以及浸润的巨噬细胞和中性粒细胞中,促炎因子 mRNA 表达和血清 IL-1β 水平降低。此外,CD36 缺乏可削弱 APAP 诱导的 c-Jun N 末端激酶(JNK)激活。有趣的是,缺乏 CD36 可降低 HMGB1 诱导的细胞外调节蛋白激酶(Erk)和 v-akt 鼠胸腺瘤病毒癌基因同源物(Akt)的激活。RNA 转录测序数据表明,HMGB1 对 WT 和 CD36 巨噬细胞有不同的作用。此外,用 PP2 治疗可减轻 APAP 诱导的小鼠肝损伤。
我们的数据表明,CD36 缺乏通过降低 JNK 激活来改善 APAP 诱导的急性肝损伤和炎症反应。CD36 可能成为减少急性肝损伤的新靶点。